One-year access to more than 500 world journals available in the system
-
http://medilib.ir
- Duration of Time : 365 Day
Price : 300$- Special Price : 100$
Health Coverage and Care for Transgender People — Threats and Opportunities
Daphna Stroumsa, M.D., M.P.H., and Anna R. Kirkland, J.D., Ph.D.
doi : 10.1056/NEJMp2032453
N Engl J Med 2020; 383:2397-2399
Failed Assignments — Rethinking Sex Designations on Birth Certificates
Vadim M. Shteyler, M.D., Jessica A. Clarke, J.D., and Eli Y. Adashi, M.D.
doi : 10.1056/NEJMp2025974
N Engl J Med 2020; 383:2399-2401
Interviewed while Black
Josh Ellis, M.D., Onyeka Otugo, M.D., M.P.H., Alden Landry, M.D., M.P.H., and Adaira Landry, M.D.
doi : 10.1056/NEJMp2023999
N Engl J Med 2020; 383:2401-2404
Trying to “Protect the NHS” in the United Kingdom
David J. Hunter, M.B., B.S., Sc.D.
doi : 10.1056/NEJMp2032508
N Engl J Med 2020; 383:e136
SARS-CoV-2 Transmission among Marine Recruits during Quarantine
Andrew G. Letizia, M.D., Irene Ramos, Ph.D., Ajay Obla, Ph.D., Carl Goforth, Ph.D., Dawn L. Weir, Ph.D., Yongchao Ge, Ph.D., Marcas M. Bamman, Ph.D., Jayeeta Dutta, M.B.A., Ethan Ellis, B.S., Luis Estrella, Ph.D., Mary-Catherine George, Ph.D., Ana S. Gonzalez-Reiche, Ph.D.,
doi : 10.1056/NEJMoa2029717
N Engl J Med 2020; 383:2407-2416
The efficacy of public health measures to control the transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has not been well studied in young adults.
An Outbreak of Covid-19 on an Aircraft Carrier
Matthew R. Kasper, Ph.D., Jesse R. Geibe, M.D., Christine L. Sears, M.D., Asha J. Riegodedios, M.S.P.H., Tina Luse, M.P.H., Annette M. Von Thun, M.D., Michael B. McGinnis, M.D., Niels Olson, M.D., Daniel Houskamp, M.D., Robert Fenequito, M.D., Timothy H. Burgess, M.D., Adam W. Armstrong, M.D.,
doi : 10.1056/NEJMoa2019375
N Engl J Med 2020; 383:2417-2426
An outbreak of coronavirus disease 2019 (Covid-19) occurred on the U.S.S. Theodore Roosevelt, a nuclear-powered aircraft carrier with a crew of 4779 personnel.
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults
Evan J. Anderson, M.D., Nadine G. Rouphael, M.D., Alicia T. Widge, M.D., Lisa A. Jackson, M.D., M.P.H., Paul C. Roberts, Ph.D., Mamodikoe Makhene, M.D., M.P.H., James D. Chappell, M.D., Ph.D., Mark R. Denison, M.D., Laura J. Stevens, M.S., Andrea J. Pruijssers, Ph.D., Adrian B. McDermott, Ph.D., Britta Flach, Ph.D.,
doi : 10.1056/NEJMoa2028436
N Engl J Med 2020; 383:2427-2438
Testing of vaccine candidates to prevent infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in an older population is important, since increased incidences of illness and death from coronavirus disease 2019 (Covid-19) have been associated with an older age.
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine Candidates
Edward E. Walsh, M.D., Robert W. Frenck, Jr., M.D., Ann R. Falsey, M.D., Nicholas Kitchin, M.D., Judith Absalon, M.D., Alejandra Gurtman, M.D., Stephen Lockhart, D.M., Kathleen Neuzil, M.D., Mark J. Mulligan, M.D., Ruth Bailey, B.Sc., Kena A. Swanson, Ph.D., Ping Li, Ph.D.,
doi : 10.1056/NEJMoa2027906
N Engl J Med 2020; 383:2439-2450
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infections and the resulting disease, coronavirus disease 2019 (Covid-19), have spread to millions of persons worldwide. Multiple vaccine candidates are under development, but no vaccine is currently available. Interim safety and immunogenicity data about the vaccine candidate BNT162b1 in younger adults have been reported previously from trials in Germany and the United States.
Severe Covid-19
David A. Berlin, M.D., Roy M. Gulick, M.D., M.P.H., and Fernando J. Martinez, M.D.
doi : 10.1056/NEJMcp2009575
N Engl J Med 2020; 383:2451-2460
Necrotizing Enterocolitis
Wontae Kim, M.D., and Jeong-Meen Seo, M.D., Ph.D.
doi : 10.1056/NEJMicm2020782
N Engl J Med 2020; 383:2461
Bronchoesophageal Fistula
Pierluigi di Mauro, M.D., and Vittorio Ferrari, M.D.
doi : 10.1056/NEJMicm2018535
N Engl J Med 2020; 383:e137
Case 39-2020: A 29-Month-Old Boy with Seizure and Hypocalcemia
Yamini V. Virkud, M.D., M.P.H., Neil D. Fernandes, M.D., Ruth Lim, M.D., Deborah M. Mitchell, M.D., and William T. Rothwell, M.D., Ph.D.
doi : 10.1056/NEJMcpc2027078
N Engl J Med 2020; 383:2462-2470
SARS-CoV-2 in the U.S. Military — Lessons for Civil Society
Nelson L. Michael, M.D., Ph.D.
doi : 10.1056/NEJMe2032179
N Engl J Med 2020; 383:2472-2473
Audio Interview: Covid-19 Vaccine Fundamentals
Eric J. Rubin, M.D., Ph.D., Lindsey R. Baden, M.D., and Stephen Morrissey, Ph.D.
doi : 10.1056/NEJMe2035370
N Engl J Med 2020; 383:e146
Cardiac Macrophages — Keeping the Engine Running Clean
Elizabeth M. McNally, M.D., Ph.D.
doi : 10.1056/NEJMcibr2030271
N Engl J Med 2020; 383:2474-2476
Racial Bias in Pulse Oximetry Measurement
doi : 10.1056/NEJMc2029240
N Engl J Med 2020; 383:2477-2478
Risk Factors for SARS-CoV-2 in a Statewide Correctional System
doi : 10.1056/NEJMc2029354
N Engl J Med 2020; 383:2479-2480
Capping or Suctioning for Tracheostomy Decannulation
doi : 10.1056/NEJMc2031385
N Engl J Med 2020; 383:2480-2481
Avelumab Maintenance for Urothelial Carcinoma
doi : 10.1056/NEJMc2032018
N Engl J Med 2020; 383:2482-2483
A Randomized Trial of Closed-Loop Control in Children with Type 1 Diabetes
doi : 10.1056/NEJMc2030417
N Engl J Med 2020; 383:2484
Racial Disproportionality in Covid Clinical Trials
doi : 10.1056/NEJMc2029374
N Engl J Med 2020; 383:2486-2490
